Based on our unique expertise in peptides, and with Lyxumia® now selling in the marketplace, we are advancing new innovative me
![Sanofi India expands diabetes portfolio, launches two diabetes drugs in India | Indiablooms - First Portal on Digital News Management Sanofi India expands diabetes portfolio, launches two diabetes drugs in India | Indiablooms - First Portal on Digital News Management](https://www.indiablooms.com/health_pic/2016/12-1468918157.jpg)
Sanofi India expands diabetes portfolio, launches two diabetes drugs in India | Indiablooms - First Portal on Digital News Management
![Optical appearance and properties of pen injection devices for approved... | Download Scientific Diagram Optical appearance and properties of pen injection devices for approved... | Download Scientific Diagram](https://www.researchgate.net/publication/346228283/figure/fig2/AS:961834261676033@1606330566243/Optical-appearance-and-properties-of-pen-injection-devices-for-approved-GLP-1-receptor_Q640.jpg)
Optical appearance and properties of pen injection devices for approved... | Download Scientific Diagram
Lixisenatide (Lyxumia®): A novel once-daily GLP-1 agonist and lead Zealand drug invention, partnered with Sanofi in Type
![An employee assembles an injection-pen for the newly launched diabetes drug Lyxumia at a manufacturing site of French drugmaker Sanofi in Frankfurt June 5, 2013. To keep its no. 2 spot in the $43 billion-a-year diabetes market, Sanofi is testing an ... An employee assembles an injection-pen for the newly launched diabetes drug Lyxumia at a manufacturing site of French drugmaker Sanofi in Frankfurt June 5, 2013. To keep its no. 2 spot in the $43 billion-a-year diabetes market, Sanofi is testing an ...](https://c8.alamy.com/zooms/6/7dd2fae642164741a046d539a162cdd9/2cyg31b.jpg)